"Not just little adults": qualitative methods to support the development of pediatric patient-reported outcomes

Rob Arbuckle1, Linda Abetz-Webb

  • 1Adelphi Values Ltd, Grimshaw Lane, Bollington, Cheshire, SK10 5JB, UK, rob.arbuckle@adelphivalues.com.

The Patient
|August 6, 2013
PubMed

Insights

Developing pediatric patient-reported outcome (PRO) measures requires careful consideration of age-specific methods and best reporters. Tailoring qualitative research and using narrow age bands ensures valid and reliable health-related quality of life (HRQL) data in children.

Area of Science:

  • Pediatric research methodology
  • Clinical trial design
  • Health outcomes research

Background:

  • Regulatory agencies like the US FDA and EMA mandate pediatric clinical research.
  • Existing guidance focuses on patient-reported outcomes (PROs) and health-related quality of life (HRQL) measure validation, but not pediatric PRO development.
  • There is a need for specific methods tailored to pediatric populations for PRO development.

Purpose of the Study:

  • To provide an overview of considerations for developing pediatric PRO measures.
  • To emphasize the importance of qualitative research for ensuring content validity in pediatric PROs.
  • To highlight age-specific challenges and best practices in pediatric PRO development.

Main Methods:

  • Literature review of pediatric PRO development methods.
  • Focus on qualitative research techniques for content validity.
  • Analysis of age-specific considerations for language, interview techniques, and sample sizes.
  • Examination of best reporter strategies (self-report, parent-report, team completion) across age bands.

Main Results:

  • Pediatric PRO development necessitates developmentally appropriate language and techniques within narrow age bands (0-17 years).
  • Qualitative research requires adequate sample sizes to ensure saturation, accounting for child development.
  • The 5-8 year age group presents challenges, often benefiting from 'team completion' (parent-administered child report) due to a balance of self-report validity and parent-report reliability.
  • Infants/toddlers (0-4 years) require parent/observer ratings of behaviors, while older children/adolescents (9+ years) generally provide valid self-reports.

Conclusions:

  • Developing pediatric PRO measures requires tailored qualitative methods and research within precise age bands.
  • The optimal reporter (child, parent, or team) depends on the child's age, developmental capacity, and the specific outcome being measured.
  • Careful consideration of the best reporting method is crucial for valid and reliable pediatric health outcomes data.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...